Inflammation-responsive drug delivery nanosystems for treatment of bacterial-induced sepsis
-
Published:2023-09
Issue:
Volume:644
Page:123346
-
ISSN:0378-5173
-
Container-title:International Journal of Pharmaceutics
-
language:en
-
Short-container-title:International Journal of Pharmaceutics
Author:
Nyandoro Vincent O.ORCID, Omolo Calvin A.ORCID, Ismail Eman A., Yong Liu, Govender Thirumala
Subject
Pharmaceutical Science
Reference152 articles.
1. Al Mamun, A., Uddin, M.S., Perveen, A., Jha, N.K., Alghamdi, B.S., Jeandet, P., et al., editors. Inflammation-targeted nanomedicine against brain cancer: From design strategies to future developments. Seminars in Cancer Biology; 2022: Elsevier. 2. Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-κB and Notch1 pathways;An;Nano Lett.,2020 3. Bahadori, F., Büyük, A.Ş., Kozanoğlu, A.S., Eskandari, Z., Ankaralı, H., Kepekçi Tekkeli, Ş.E., et al. , 2019.Preparation and evaluation of inflammation targeted nano-micellar formulation of celecoxib.. 4. Iseganan HCl: a novel antimicrobial agent;Bellm;Expert Opin. Invest. Drugs,2002 5. pH and reactive oxygen species-sequential responsive nano-in-micro composite for targeted therapy of inflammatory bowel disease;Bertoni;Adv. Funct. Mater.,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|